title: Management of ligneous conjunctivitis in a child with plasminogen deficiency.
abstract: Plasminogen deficiency, a rare autosomal recessive disorder, is classified as type I (hypoplasminogenemia) or type II (dysplasminogenemia). Hypoplasminogenemia is characterized by impaired wound healing while ligneous conjunctivitis (LC) is its main manifestation presenting with redness of the conjunctivae and progression to pseudomembranes' formation on the palpebral surfaces. A 4-year-old girl with LC in her left eye and impaired vision was referred to our unit. The conjunctival membranes had been already excised twice, followed by recurrences. Soon after the third recurrence, a probable diagnosis of LC was suggested, confirmed by a reduced plasminogen activity at 20% (normal values 80-120%). Both of her parents have slightly reduced plasminogen levels (50-60%) without any relevant symptom. Fresh frozen plasma (FFP) was administered systemically and topically, initiating 2 days before surgical removal of pseudomembranes with electrocautery under general anaesthesia. Systemic FFP was administered for 12 days postoperatively, along with topical use; the later was continued thereafter for 3 months. No recurrence was noticed. The vision was improved. Two weeks after cessation of the topical treatment, pseudomembranes reappeared. Topical application of FFP was reinitiated soon thereafter, and the girl underwent a second operation to have the conjunctival pseudomembranes removed. The perioperative therapeutic management was as previously described. Systemic treatment was stopped at the end of the tenth day while topical application of FFP was being continued until now, 10 months postoperatively. No recurrence has been observed and the vision remains at 9/10.
  
  
  CONCLUSIONS
  Since surgical excision of the conjunctival pseudomembranes alone in patients with LC does not protect from recurrences, the perioperative administration of FFP, both systemically and topically improves the outcome. Furthermore, the long-term application of topical FFP preparations seems to prevent recurrences and has a protective effect on the vision of these patients.
authors.affiliation: Haemophilia Centre/Haemostasis Unit, Aghia Sophia Children's Hospital, Athens GR11527, Greece. haemofilia@paidon-agiasofia.gr
authors.forename: Helen
authors.initials: H
authors.lastname: Pergantou
authors.forename: Dimitra
authors.initials: D
authors.lastname: Likaki
authors.forename: Maria
authors.initials: M
authors.lastname: Fotopoulou
authors.forename: Olga
authors.initials: O
authors.lastname: Katsarou
authors.forename: Panagiota
authors.initials: P
authors.lastname: Xafaki
authors.forename: Helen
authors.initials: H
authors.lastname: Platokouki
mesh_terms: D060433:Administration, Ophthalmic; D001778:Blood Coagulation Disorders / Q000628:therapy; D002675:Child, Preschool; D003231:Conjunctivitis / Q000601:surgery / Q000628:therapy*; D004564:Electrocoagulation; D005260:Female; D005343:Fibrinolytic Agents; D005500:Follow-Up Studies; D006801:Humans; D007262:Infusions, Intravenous; D010949:Plasma; D010958:Plasminogen / Q000172:deficiency*; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010958:Plasminogen